Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HD-Tdcs Associated With The Use Of Dexmedetomidine For Delirium In Critical Patients With Covid-19

NCT05963958 is registered in ClinicalTrials.gov with Suellen Andrade as lead sponsor.

NCT NCT05963958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05963958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HD-Tdcs Associated With The Use Of Dexmedetomidine For Delirium In Critical Patients With Covid-19
Lead sponsor
Suellen Andrade
Phase
Not applicable
Overall status
Completed
Start date
April 14, 2021
Completion date
January 30, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, critical illness, delirium